ACHN 2018 Proxy Statement

DIRECTOR COMPENSATION The following table sets forth information concerning the compensation of our non-employee directors for the fiscal year ended December 31, 2017. Director Compensation Name Fees Earned or Paid in Cash ($) Option Awards ($)(1)(2) All Other Compensation ($) Total ($) Jason Fisherman, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . 72,675 87,037 — 159,712 Gary Frashier . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69,625 87,037 — 156,662 Kurt Graves . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71,875 87,037 — 158,912 Michael D. Kishbauch . . . . . . . . . . . . . . . . . . . . . . . . . . . 61,175 87,037 — 148,212 David Scheer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112,500 87,037 — 199,537 Robert Van Nostrand . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77,500 87,037 — 164,537 Frank Verwiel, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77,625 87,037 — 164,712 Nicole Vitullo . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62,500 87,037 — 149,537 (1) The amounts in this column reflect the aggregate grant date fair value of the option awards granted for the fiscal year ended December 31, 2017, in accordance with ASC 718, Stock Compensation . There can be no assurance that the ASC 718 amounts will ever be realized. The assumptions we used to calculate these amounts are included in Note 11 to our audited financial statements for fiscal 2017, included in our annual report on Form 10-K for the fiscal year ended December 31, 2017 filed with the SEC on February 22, 2018. (2) The number of shares underlying stock options granted to our directors in 2017 are: Name Grant Date Number of Shares Underlying Stock Option Grants in 2017(#) Jason Fisherman, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 01/19/2017 30,000 Gary Frashier . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 01/19/2017 30,000 Kurt Graves . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 01/19/2017 30,000 Michael D. Kishbauch . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 01/19/2017 30,000 David Scheer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 01/19/2017 30,000 Robert Van Nostrand . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 01/19/2017 30,000 Frank Verwiel, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 01/19/2017 30,000 Nicole Vitullo . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 01/19/2017 30,000 The aggregate outstanding options for each non-employee director as of December 31, 2017 are: Name Aggregate Options Outstanding(#) Jason Fisherman, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 240,000 Gary Frashier . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 178,750 Kurt Graves . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 265,000 Michael D. Kishbauch . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116,250 David Scheer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 250,000 Robert Van Nostrand . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 250,000 Frank Verwiel, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90,000 Nicole Vitullo . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 200,000 54